In-Vitro Transcription Templates Market Report 2024: Size, Share, Growth, Trends, Forecast 2033

The new report published by The Business Research Company, titled ""In-Vitro Transcription Templates Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the in-vitro transcription templates market size has grown exponentially in recent years. It will grow from $0.82 billion in 2023 to $1.01 billion in 2024 at a compound annual growth rate (CAGR) of 23.4%. The in-vitro transcription templates market size is expected to see exponential growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15836&type=smp

Gene Therapy Advancements Drive Growth In In-Vitro Transcription Templates Market
The increasing focus on gene therapy is expected to propel the growth of the in-vitro transcription templates market. Gene therapy involves modifying genes within cells to treat or prevent diseases by correcting defective genes. Advances in technologies such as CRISPR, significant investment, and recent treatment successes have increased focus on this approach. In-vitro transcription templates help in gene therapy by providing the RNA molecules necessary for mRNA-based therapies, siRNA-based therapies, and gene editing technologies, enabling the treatment of genetic disorders and diseases. For instance, in March 2024, the Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services, estimated that 36 gene therapies were approved by the FDA, with an additional 500 in the pipeline and the expectation that 10-20 will be approved annually by 2025. Therefore, the increasing focus on gene therapy is driving the growth of the in-vitro transcription templates market.

Innovative Advancements In In-Vitro Transcription Technology Transform Biotechnology Landscape
Major companies operating in the in-vitro transcription templates market are developing self-amplifying RNA synthesis services to enhance the efficiency and effectiveness of RNA-based therapies, reduce production costs, and improve patient outcomes in various therapeutic applications. Self-amplifying RNA synthesis service is a technology that enables the production of RNA capable of replicating itself within host cells, leading to enhanced protein expression from minimal RNA input, thereby improving the efficiency and effectiveness of RNA-based therapies. For instance, in May 2024, GenScript Biotech Corporation, a US-based biotechnology company, launched a self-amplifying RNA (saRNA) synthesis service, expanding its in vitro transcription RNA synthesis portfolio. This new service enhances the potency and efficacy of vaccines, immunotherapies, and gene therapies by enabling robust protein expression from a small amount of RNA. The saRNA platform promises to reduce dosages, lower production costs, and improve patient outcomes. Supported by extensive research and development, GenScript's saRNA exhibits high purity and enhanced protein expression, ensuring reliable performance.

The in-vitro transcription templates market covered in this report is segmented -
1) By Treatment: Vaccine, Therapeutic
2) By Research Stage: Exploratory, Clinical
3) By Disease: Cancer, Infectious Disease, Lifestyle Disease, Genetic Disease, Other Diseases
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academics And Research, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15836&type=discount

Major companies operating in the in-vitro transcription templates market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Integrated DNA Technologies Inc., Promega Corporation, Genescript Biotech Corporation, Takara Bio Inc., New England Biolabs, OriGene Technologies Inc., Cayman Chemical, Synthego Corporation, Synbio Technologies, Creative Diagnostics, VectorBuilder Inc., Bio-Synthesis Inc., TriLink BioTechnologies, Norgen Biotek Corporation, Genaxxon BioScience GmbH, Enzo Life Sciences Inc., GeneCopoeia

Contents of the report:
1. Executive Summary
2. In-Vitro Transcription Templates Market Report Structure
3. In-Vitro Transcription Templates Market Trends And Strategies
4. In-Vitro Transcription Templates Market - Macro Economic Scenario
5. In-Vitro Transcription Templates Market Size And Growth
…..
27. In-Vitro Transcription Templates Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/invisible-orthodontics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.